Abstract
The progression of carotid atherosclerosis in lupus patients is frequently encountered, and it is determined by both traditional and nontraditional risk factors. Of the 181 patients initially included in the study, 157 patients were reevaluated after 39(37–42) months. The progression of atherosclerosis was defined as the increase in the intima-media thickness (IMT) >0.15 mm and/or an increase of the plaque score. The predictive factors of progression were identified using the Poisson regression model. The median of the cohort age at baseline was 38 years (range 29–46 years; 96.2% female, 75.8% nonwhite). Carotid atherosclerosis progression was observed in 43 patients (27.4%), an increased plaque score was observed in nine patients (5.7%), an increase of IMT >0.15 mm was observed in 31 (19.7%), and both issues were present in three patients (1.9%). The univariate determinants of atherosclerosis progression were age, systemic lupus erythematosus (SLE) duration, and higher serum level of triglycerides (p < 0.05). The presence of nephrotic proteinuria (p = 0.063), stage 3 or greater chronic kidney disease (p = 0.091), and longer duration of prednisone use (p = 0.056) showed a tendency towards association with progression of atherosclerosis. The independent risk factors for progression were the SLE duration (p = 0.008, RR = 1.06, 95% CI = 1.03–1.10) and the presence of nephrotic proteinuria (p = 0.022, RR = 4.22, 95% CI = 2.18–8.15). The progression of atherosclerosis occurred in a substantial number of young SLE patients during a short-term follow-up. The independent factors associated with this progression emphasize the importance of SLE in determining atherosclerosis in these individuals.
Similar content being viewed by others
References
Bessant R, Hingorani A, Patel L, MacGregor A, Isemberg DA, Rahman A (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatol 43(7):924–929
Roman MJ, Shanker B-A, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399–2406
Telles RW, Lanna CCD, Ferreira GA, Souza AJ, Navarro TP, Ribeiro AL (2008) Carotid atherosclerotic alterations in systemic lupus erythematosus treated at a Brazilian university setting. Lupus 17(2):105–113
Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145(5):408–415
Toloza SM, Uribe AG, McGwin GJ et al (2004) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events. Arthritis Rheum 50(12):3947–3957
Kanters SDJM, Algra A, van Leeuwen MS, Banga J-D (1997) Reproducibility of in vivo carotid intima-media thickness measurements - A Review. Stroke 28(3):665–671
Sutton-Tyrrel K, Wolfson SK Jr, Thompson T, Kelsey SF (1992) Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 23(2):215–220
Burke GL, Evans GW, Riley A et al (1995) Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults—the atherosclerosis risk in communities (ARIC) study. Stroke 26(3):386–391
Van der Meer IM, Del Sol AI, Hak E, Bots ML, Hofman A, Witteman JCM (2003) Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree—the Rotterdam study. Stroke 34(10):2374–2379
De Leeuw K, Smit AJ, de Groot E, Vanroon AM, Kallenberg CG, Bijl M (2009) Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 206(2):546–550
Roman MJ, Crow MK, Lockshin MD et al (2007) Rate determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 56(10):3412–3419
Rua-Figueroa I, Arencibia-Mireles O, Elvira M, et al. (2009) The factors involved in the progression of preclinical atherosclerosis associated with lupus erythematosus: a two year longitudinal study. Ann Rheum Dis ;Epub ahead of print
Thompson T, Sutton-Tyrrell K, Wildman RP et al (2008) Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 58(3):835–842
Telles RW, Lanna CCD, Ferreira GA, Carvalho MAP, Ribeiro AL (2007) Frequência de doença cardiovascular aterosclerótica e de seus fatores de risco em pacientes com lúpus eritematoso sistêmico. Rev Bras Reum 47(3):165–172
Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837–1847
(2001) Executive Summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA;285(19):2486–97
Gladman DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291
Uribe AG, Vilá LM Jr, McGwin G Jr, Sanchez ML, Reveille JD, Alarcón GS (2004) The systemic lupus activity measure-revised, the Mexican systemic lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31(10):1934–1940
Gladman DD, Ginzler EM, Goldsmith C et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369
Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome-Report of an international workshop. Arthritis Rheum 42(7):1309–1311
Cockcroft D, Gault MK (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310
de Vet HCW, Terwee CB, Knol DL, Bouter LM (2006) When to use agreement versus reliability measures. J Clin Epidemiol 59:1033–1039
Currier JS, Kendall MA, Henry WK et al (2007) Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 21(9):1137–1145
Falaschi F, Ravelli A, Martignoni A et al (2000) Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 43(6):1405–1409
Harouri B, Liu PP, Papp KA (2012) Clin Rheumatol 31:585–594
Tesar V, Jirsa M Jr, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J (2002) Med Sci Monit 8(1):BR24–BR29
Acknowledgment
Pro-reitoria de Pesquisa da Universidade Federal de Minas Gerais.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Telles, R.W., Lanna, C.C.D., Sousa, A.J. et al. Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol 32, 1293–1300 (2013). https://doi.org/10.1007/s10067-013-2264-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2264-9